AstraZeneca
AZN
AZN
556 hedge funds and large institutions have $17.7B invested in AstraZeneca in 2018 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 144 increasing their positions, 215 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.19% more ownership
Funds ownership: 34.56% → 36.75% (+2.2%)
2% more capital invested
Capital invested by funds: $17.3B → $17.7B (+$312M)
33% less repeat investments, than reductions
Existing positions increased: 144 | Existing positions reduced: 215
Holders
556
Holding in Top 10
5
Calls
$131M
Puts
$67.3M
Top Buyers
| 1 | +$799M | |
| 2 | +$230M | |
| 3 | +$230M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$56.9M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$55M |
Top Sellers
| 1 | -$80.6M | |
| 2 | -$79.2M | |
| 3 | -$61.7M | |
| 4 |
EIP
Epoch Investment Partners
New York
|
-$57.3M |
| 5 |
BlackRock
New York
|
-$53.2M |